INCREASED SERUM APOLIPOPROTEIN(A) IN PATIENTS WITH CHRONIC-RENAL-FAILURE TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS

被引：31

作者：

MURPHY, BG

MCNAMEE, P

DULY, E

HENRY, W

ARCHBOLD, P

TRINICK, T

机构：

[1] BELFAST CITY HOSP,DEPT MED,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND

[2] BELFAST CITY HOSP,DEPT CLIN CHEM,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND

[3] ULSTER HOSP,BELFAST,NORTH IRELAND

来源：

ATHEROSCLEROSIS | 1992年 / 93卷 / 1-2期

关键词：

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD); APOLIPOPROTEIN(A); LIPOPROTEIN(A); CHOLESTEROL;

D O I：

10.1016/0021-9150(92)90199-Q

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with end-stage renal failure (ESRF) on renal replacement therapy are at significantly increased risk of cardiovascular disease. To determine whether altered concentrations of apolipoprotein(a) (apo(a)), the plasminogen-like protein moiety of the atherogenic particle lipoprotein(a), contributed to this increased risk, apo(a) concentrations were measured in 48 non-diabetic patients with ESRF treated by continuous ambulatory peritoneal dialysis (CAPD) therapy and compared with 65 controls. Apo(a) concentration was increased in CAPD patients compared to controls (geometric mean 419 units/l versus 137 units/l; ratio of means 3.06 (95% CI 1.95-4.80). We conclude that CAPD patients have increased apo(a) concentrations which may contribute to their increased risk of cardiovascular disease.

引用

页码：53 / 57

页数：5

共 28 条

[1] LIPOPROTEIN(A) IN PATIENTS TREATED BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
THILLET, J
FAUCHER, C
ISSAD, B
ALLOUACHE, M
CHAPMAN, J
JACOBS, C
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) : 226 - 232
[2] HIGH SERUM LIPOPROTEIN(A) CONCENTRATIONS IN UREMIC PATIENTS TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
SHOJI, T
NISHIZAWA, Y
NISHITANI, H
YAMAKAWA, M
MORII, H
CLINICAL NEPHROLOGY, 1992, 38 (05) : 271 - 276
[3] SERUM-LIPOPROTEIN (A) CONCENTRATIONS IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
ANWAR, N
BHATNAGAR, D
SHORT, CD
MACKNESS, MI
DURRINGTON, PN
PRAIS, H
GOKAL, R
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (01) : 71 - 74
[4] MULTICENTER STUDY OF LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPES IN PATIENTS WITH END-STAGE RENAL-DISEASE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
KRONENBERG, F
KONIG, P
NEYER, U
AUINGER, M
PRIBASNIG, A
LANG, U
REITINGER, J
PINTER, G
UTERMANN, G
DIEPLINGER, H
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (01): : 110 - 120
[5] LIPOPROTEIN (A) IN PATIENTS ON MAINTENANCE HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
WEBB, AT
REAVELEY, DA
ODONNELL, M
OCONNOR, B
SEED, M
BROWN, EA
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (07) : 609 - 613
[6] SERUM LIPOPROTEIN(A) CONCENTRATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE RECEIVING HEMODIALYSIS - INFLUENCE OF APOLIPOPROTEIN(A) GENETIC-POLYMORPHISM
AUGUET, T
SENTI, M
RUBIESPRAT, J
PELEGRI, A
PEDROBOTET, J
NOGUES, X
ROMERO, R
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (10) : 1099 - 1103
[7] Increased plasma concentrations of lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis
Gazzaruso, C
Bonetti, G
Garzaniti, A
Pini, G
Ragazzoni, A
Bianchi, C
Jucci, A
Buscaglia, P
Geroldi, D
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1996, 6 (04) : 203 - 210
[8] Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose
Heimburger, O
Stenvinkel, P
Berglund, L
Tranaeus, A
Lindholm, B
NEPHRON, 1996, 72 (02): : 135 - 144
[9] Cardiovascular risk in continuous ambulatory peritoneal dialysis patients
Culleton, B
Parfrey, PS
PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (01): : 10 - 12
[10] Elevated lipoprotein(a) and fibrinogen serum levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients
Bartens, W
Nauck, M
Schollmeyer, P
Wanner, C
PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (01): : 27 - 33

← 1 2 3 →